Plyzer Technologies signs pharma company Heel as a SaaS client for its business analytics platform, Plyzer Intelligence
Plyzer continues to build sales momentum and expects more to come over the coming weeks and months
Plyzer Technologies (OTCQB:PLYZ)
2020 will be a breakout year for Plyzer.We are very excited about our prospects to generate revenues and profits selling our business intelligence software”
TORONTO, ONTARIO, CANADA, January 6, 2020 /EINPresswire.com/ -- Plyzer Technologies Inc. (PLYZ: OTCQB) is pleased to announce that it has signed the pharmaceutical company Heel, which specializes in developing and manufacturing medicines made from natural ingredients, as a new SaaS customer for its business analytics software, Plyzer Intelligence.— Luis Pallares
Heel is a German company that employs more than 1,350 people worldwide. The company's turnover in 2018 was over €200 million. More information about Heel can be found by visiting > www.heel.com
“Heel is a pioneer in the field of natural medicine, a flourishing industry in the e-commerce space. We look forward to helping Heel generate more sales through the intelligent use of data ”, said Luis Pallares, founder and CEO of Plyzer Technologies Corporation.
Luis Pallares
Plyzer Technologies
+1 416-860-0211
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Luis Pallares presents what Plyzer Technologies sells
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
